Cantourage Group SE Stock

Equities

HIGH

DE000A3DSV01

Drug Retailers

Market Closed - Xetra 11:36:17 2024-04-26 am EDT 5-day change 1st Jan Change
8.15 EUR -1.21% Intraday chart for Cantourage Group SE +9.40% +13.51%
Sales 2023 * 23.6M 25.23M Sales 2024 * 39.2M 41.91M Capitalization 102M 109M
Net income 2023 * -3M -3.21M Net income 2024 * -2M -2.14M EV / Sales 2023 * 4.18 x
Net cash position 2023 * 2.9M 3.1M Net cash position 2024 * 1.9M 2.03M EV / Sales 2024 * 2.54 x
P/E ratio 2023 *
-32.6 x
P/E ratio 2024 *
-47.9 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.21%
1 week+9.40%
Current month-1.81%
1 month+6.54%
3 months+35.16%
6 months-7.07%
Current year+13.51%
More quotes
1 week
7.55
Extreme 7.55
8.55
1 month
7.40
Extreme 7.4
9.10
Current year
5.86
Extreme 5.86
11.00
1 year
5.86
Extreme 5.86
13.80
3 years
5.86
Extreme 5.86
40.50
5 years
5.86
Extreme 5.86
40.50
10 years
5.86
Extreme 5.86
40.50
More quotes
Date Price Change Volume
24-04-26 8.15 -1.21% 614
24-04-25 8.25 -0.60% 4,975
24-04-24 8.3 +2.47% 2,791
24-04-23 8.1 +6.58% 2,670
24-04-22 7.6 +2.01% 1,742

Delayed Quote Xetra, April 26, 2024 at 11:36 am EDT

More quotes
Cantourage Group SE is a Germany-based holding company. The Company offers products in market segments such as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. The object of Cantourage GmbH is the production of and wholesale trade in cannabis-based medicinal preparations and trade in other cannabis products.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.15 EUR
Average target price
10 EUR
Spread / Average Target
+22.70%
Consensus

Annual profits - Rate of surprise